A former Maryland resident was sentenced on Tuesday to more than one year behind bars for making thousands of threatening and harassing telephone calls to dozens of congressional ...

"Lilly Pulitzer" from publisher Assouline is a hard-cover, pink toile-lined celebration of designer and brand on the fashion line's 65th anniversary, updated from the 60th anniversary edition.

Eli Lilly said it has started selling single-dose vials of its uber-popular weight-loss drug Zepbound as demand soars – and the smaller doses cost 50% less than rival drugs. The more affordable ...

Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand ...

Eli Lilly has launched a new program that will allow self-pay patients to purchase the weight-loss drug Zepbound for as little as $399 per month—less than half the list price of other incretin ...

But Alabama? None. Nada. Zero. Zilch. The birthplace of world-famous Alabama white sauce and the home of barbecue legends ...

Eli Lilly will begin offering its popular new weight-loss drug Zepbound in vials—in addition to standard injection-pen devices—at about half the price of the original for certain doses.

For context, the drug originally launched last year at a list price of $1,059, which Lilly said was approximately 20% lower than Novo Nordisk’s competing semaglutide products. Novo’s obesity ...

Eli Lilly & Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots.

Lilly Launches Vials of Weight-Loss Drug Zepbound for as Low as $399 a Month By Patrick Wingrove (Reuters) - Eli Lilly said on Tuesday it has begun selling vials of the lowest starter dose of its ...

Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Using telehealth to sell drugs straight to patients. The company launched a website ...